2m 2m 2m 2m 2m 2m 2m
AVALO THERAP (AVTX)
NASDAQ
$18.39+$0.14 (+0.77%)
Price as of Aug 03, 2026 10:19 AM EDT- $965.5MMarket Cap
- 131.31%1-Year Change
- BiotechnologyIndustry
AVALO THERAP (AVTX)
$18.39+$0.14 (+0.77%)
AVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.25 | ||
Change | -$1.14 (-5.88%) | ||
Open | $19.50 | ||
High | $19.73 | ||
Low | $18.24 | ||
Previous Close | $19.39 | ||
Volume | 923,877 | ||
30-Day Average Volume | 1,045,470 | ||
1-Week Change | -1.03% | ||
1-Month Change | -1.24% | ||
1-Year Change | 131.31% | ||
3-Year Change | -61.98% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 52.9M | ||
Total Assets | $99.9M | ||
Market Cap | $965.5M | ||
Enterprise Value | $940.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$19.6M | ||
Free Cash Flow | -$25.2M | ||
EBIT | -$19.6M | ||
EBITDA | -$19.6M | ||
Net Working Capital | $77.2M | ||
EPS | -$0.98 | ||
Enterprise Value/EBITDA | -48 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 14 | ||
P/E | -19 | ||
PEG | 1 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 240 | ||
Last Split Date | 12/29/2023 | ||
Earnings & Revenue